vs
AMREP CORP.（AXR）与Gossamer Bio, Inc.（GOSS）财务数据对比。点击上方公司名可切换其他公司
AMREP CORP.的季度营收约是Gossamer Bio, Inc.的1.1倍（$14.6M vs $13.8M），AMREP CORP.净利率更高（21.6% vs -342.3%，领先363.9%），AMREP CORP.同比增速更快（93.8% vs 47.1%）
AMREP是一家总部位于美国新泽西州普林斯顿的企业，核心业务涵盖房地产与媒体服务领域。公司前身为美国地产石油公司，于1961年正式成立，在相关行业拥有六十余年的发展运营历史。
Gossamer Bio是一家临床阶段生物制药企业，专注于发现、开发和商业化用于治疗免疫、炎症和肿瘤领域重症疾病的创新疗法，推进多条自研候选药物管线进入不同临床阶段，主要面向北美及全球其他地区的医疗市场。
AXR vs GOSS — 直观对比
营收规模更大
AXR
是对方的1.1倍
$13.8M
营收增速更快
AXR
高出46.7%
47.1%
净利率更高
AXR
高出363.9%
-342.3%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.6M | $13.8M |
| 净利润 | $3.1M | $-47.2M |
| 毛利率 | — | — |
| 营业利润率 | 20.6% | -333.6% |
| 净利率 | 21.6% | -342.3% |
| 营收同比 | 93.8% | 47.1% |
| 净利润同比 | 338.9% | -43.0% |
| 每股收益（稀释后） | $0.58 | $-0.21 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXRGOSS
| Q1 26 | $14.6M | — | ||
| Q4 25 | $9.4M | $13.8M | ||
| Q3 25 | $17.9M | $13.3M | ||
| Q2 25 | $11.2M | — | ||
| Q1 25 | $7.5M | — | ||
| Q4 24 | $11.9M | — | ||
| Q3 24 | $19.1M | — | ||
| Q2 24 | $19.5M | $95.8M |
净利润AXRGOSS
| Q1 26 | $3.1M | — | ||
| Q4 25 | $1.2M | $-47.2M | ||
| Q3 25 | $4.7M | $-48.2M | ||
| Q2 25 | $3.9M | — | ||
| Q1 25 | $717.0K | — | ||
| Q4 24 | $4.0M | — | ||
| Q3 24 | $4.1M | — | ||
| Q2 24 | $4.1M | $49.2M |
营业利润率AXRGOSS
| Q1 26 | 20.6% | — | ||
| Q4 25 | 11.9% | -333.6% | ||
| Q3 25 | 34.4% | -369.4% | ||
| Q2 25 | 31.7% | — | ||
| Q1 25 | 5.7% | — | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 26.1% | — | ||
| Q2 24 | 23.9% | 54.3% |
净利率AXRGOSS
| Q1 26 | 21.6% | — | ||
| Q4 25 | 12.8% | -342.3% | ||
| Q3 25 | 26.3% | -362.7% | ||
| Q2 25 | 34.8% | — | ||
| Q1 25 | 9.5% | — | ||
| Q4 24 | 33.9% | — | ||
| Q3 24 | 21.3% | — | ||
| Q2 24 | 21.2% | 51.4% |
每股收益（稀释后）AXRGOSS
| Q1 26 | $0.58 | — | ||
| Q4 25 | $0.22 | $-0.21 | ||
| Q3 25 | $0.87 | $-0.21 | ||
| Q2 25 | $0.73 | — | ||
| Q1 25 | $0.13 | — | ||
| Q4 24 | $0.75 | — | ||
| Q3 24 | $0.76 | — | ||
| Q2 24 | $0.77 | $0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $50.0M | $136.9M |
| 总债务越低越好 | $21.0K | — |
| 股东权益账面价值 | $139.4M | $-122.8M |
| 总资产 | $143.9M | $172.2M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资AXRGOSS
| Q1 26 | $50.0M | — | ||
| Q4 25 | $44.6M | $136.9M | ||
| Q3 25 | $48.9M | $180.2M | ||
| Q2 25 | $39.5M | — | ||
| Q1 25 | $36.9M | — | ||
| Q4 24 | $40.1M | — | ||
| Q3 24 | $40.4M | — | ||
| Q2 24 | $29.7M | $354.5M |
总债务AXRGOSS
| Q1 26 | $21.0K | — | ||
| Q4 25 | $23.0K | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | $26.0K | — | ||
| Q1 25 | $29.0K | — | ||
| Q4 24 | $32.0K | — | ||
| Q3 24 | $34.0K | — | ||
| Q2 24 | $35.0K | — |
股东权益AXRGOSS
| Q1 26 | $139.4M | — | ||
| Q4 25 | $136.0M | $-122.8M | ||
| Q3 25 | $134.7M | $-82.3M | ||
| Q2 25 | $130.0M | — | ||
| Q1 25 | $126.0M | — | ||
| Q4 24 | $125.1M | — | ||
| Q3 24 | $122.2M | — | ||
| Q2 24 | $118.0M | $81.5M |
总资产AXRGOSS
| Q1 26 | $143.9M | — | ||
| Q4 25 | $140.1M | $172.2M | ||
| Q3 25 | $140.7M | $208.8M | ||
| Q2 25 | $133.8M | — | ||
| Q1 25 | $128.9M | — | ||
| Q4 24 | $129.1M | — | ||
| Q3 24 | $127.0M | — | ||
| Q2 24 | $122.8M | $373.4M |
负债/权益比AXRGOSS
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.4M | $-48.3M |
| 自由现金流经营现金流 - 资本支出 | $5.4M | — |
| 自由现金流率自由现金流/营收 | 37.0% | — |
| 资本支出强度资本支出/营收 | 0.1% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | $20.2M | — |
8季度趋势，按日历期对齐
经营现金流AXRGOSS
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $-48.3M | ||
| Q3 25 | $9.5M | $-36.2M | ||
| Q2 25 | $10.2M | — | ||
| Q1 25 | $-3.2M | — | ||
| Q4 24 | $-182.0K | — | ||
| Q3 24 | $10.7M | — | ||
| Q2 24 | $10.7M | $116.3M |
自由现金流AXRGOSS
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $9.5M | — | ||
| Q2 25 | $9.7M | — | ||
| Q1 25 | $-3.3M | — | ||
| Q4 24 | $-268.0K | — | ||
| Q3 24 | $10.7M | — | ||
| Q2 24 | $10.3M | — |
自由现金流率AXRGOSS
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 86.4% | — | ||
| Q1 25 | -43.4% | — | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | 55.8% | — | ||
| Q2 24 | 52.5% | — |
资本支出强度AXRGOSS
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | 0.3% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 2.3% | 0.0% |
现金转化率AXRGOSS
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | — | ||
| Q3 25 | 2.03× | — | ||
| Q2 25 | 2.63× | — | ||
| Q1 25 | -4.51× | — | ||
| Q4 24 | -0.05× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 2.59× | 2.36× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
